Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumab
S Gliga, P Massion, C Ackermann, C de Angelis… - 2024 - researchsquare.com
Purpose: The IL-6 receptor inhibitor tocilizumab reduces mortality and morbidity in severe
cases of COVID-19 through its effects on hyperinflammation and was approved as adjuvant …
cases of COVID-19 through its effects on hyperinflammation and was approved as adjuvant …
Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumab
S Gliga, P Massion, C Ackermann, C de Angelis… - 2024 - europepmc.org
Purpose: The IL-6 receptor inhibitor tocilizumab reduces mortality and morbidity in severe
cases of COVID-19 through its effects on hyperinflammation and was approved as adjuvant …
cases of COVID-19 through its effects on hyperinflammation and was approved as adjuvant …